On January 30, 2023, Apexigen, Inc. closed the transaction. The company issued 1,995,708 common shares at an issue price of $1.4 per share for aggregate gross proceeds of approximately $2,793,991.2. The transaction included participation from 13 investors. The company paid finder's fee of $45,000 for the transaction.
1st Jan change | Capi. | |
---|---|---|
+11.91% | 118B | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.82% | 21.96B | |
-10.12% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B |